维普中文期刊产品整合服务
79篇 您的检索式:作者名="Yanagihara F"
    题名 作者 年代 出处 被引量
1Evalutation of angiogenesis in non - small cell lung cancer: comparsion bettween anti - CD34 antibody and anti- CD105 antibody 显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Cancer Res2001,7,11:1
2Expression of angiopoietins and its clinical significance in non-small cell lung cancer显示文摘Tanaka F Ishikawa S Yanagihara K 2002Cancer Res2002,62,71:1
3Expression of Angiopoietins and Its Clinical Significance in Non-Small Cell Lung Cancer 显示文摘Tanaka F Ishikawa S Yanagihara K 2002Cancer Res2002,62,23:1
4Expression of angiopoietins and its clinical significance in non-small cell lung cancer 显示文摘Tanaka F Ishikawa S Yanagihara K 2002Cancer Res2002,62,23:1
5Evaluation of angiogenesis in non-smal cel lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody显示文摘Tanaka F Otake Y Yanagihara K Kawano Y Miyahara R Li M 2001Clin Cancer Res2001,7,11:1
6Evaluation of angio- genesis in non-small cell lung cancer: comparison between anti - CD34 antibody and anti-CD105 antibody 显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Cancer Res2001,7,:1
7Correlation between apoptotic index and angiogenesis in non-small cell lung cancer:comparison between CD105 and CD34 as a marker of angiogenesis显示文摘Tanaka F Otake Y Yanagihara K 2003Lung Cancer2003,39,:1
8Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)显示文摘Tanaka F Yanagihara K Otake Y 2001Fur J Cardiothorac Surg2001,19,:1
9Evaluation of angiogene- sis in non-small cell lung cancer 显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Can Res2001,7,11:1
10Evaluation of angiogensis in non-small cell lung cancer:comparison betwenn their CD34 antibody and their CD105 antibody显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Cancer Res2001,7,:1
11Efficacy of azithromycin in the treatment of community-acquired pneumonia,including patients with macrolide-resistant Streptococcus pneumoniae infection显示文摘Yanagihara K Izumikawa K Higa F 2009Intern Med2009,48,7:1
12Correlation between apoptotic index and angiogenesis in non-small cell lung cancer:comparison between CD105 and CD34 as a marker of angiogenesis显示文摘Tanaka F Otake Y Yanagihara K 2003Lung Cancer2003,39,3:1
13Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody显示文摘 Otake Y Yanagihara K 2001Clin Cancer Res2001,7,11:1
14Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Cancer Res2001,7,11:1
15Expression of angiopoietins and its clinical significance in non-small cell lung cancer显示文摘Tanaka F Ishikawa S Yanagihara K 2002Cancer Res2002,62,23:1
16Evaluation of angiogenesis in non-small cell lung cancer comparison between anti-CD34 antibody and anti-CDl05 antibody显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Cancer Res2001,,:1
17Intcrperitoneal dlivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice显示文摘Fujita T Yanagihara K Takeshita F 2013Cancer Sci2013,104,2:1
18Expression of angiopoietins and its clinical significance in non-small cell lung cancer显示文摘Tanaka F Ishikawa S Yanagihara K 0,,23:1
19Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CDlO5 antibody 显示文摘TANAKA F OTAKE Y YANAGIHARA K 2001Clin Cancer Res2001,7,11:1
20Evaluation of angiogenesisin non-small cell lung cancer:comparison between anti-CD34 antibodyand anti-CDlc~ antibody 显示文摘Tanaka F Otake Y Yanagihara K 2001Clin Cancer Res2001,7,11:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费